Effects of Metformin, Metformin Plus Rosiglitazone, and Metformin Plus Lifestyle on Insulin Sensitivity and β-Cell Function in TODAY

OBJECTIVE: The Treatment Options for type 2 Diabetes in Adolescents and Youth (TODAY) trial demonstrated that combination therapy with metformin plus rosiglitazone provided superior durability of glycemic control compared with metformin alone, with significantly lower treatment failure rates (38.6 v...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3661836/
https://www.ncbi.nlm.nih.gov/pubmed/23704674
http://dx.doi.org/10.2337/dc12-2393

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3661836/
https://www.ncbi.nlm.nih.gov/pubmed/23704674
http://dx.doi.org/10.2337/dc12-2393

Ejemplares similares